Pharmacokinetics of Low Dose Raltegravir.
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2013
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
- 04 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2010 New trial record